Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 40 |
Descriptor
Source
| Journal of the American… | 65 |
Author
| Vitiello, Benedetto | 10 |
| Kratochvil, Christopher | 6 |
| March, John | 6 |
| Silva, Susan | 6 |
| Pathak, Sanjeev | 5 |
| Weller, Elizabeth | 5 |
| Cunningham, Charles | 4 |
| Davies, Mark | 4 |
| Ghuman, Jaswinder | 4 |
| Posner, Kelly | 4 |
| Reinecke, Mark | 4 |
| More ▼ | |
Publication Type
| Journal Articles | 65 |
| Reports - Research | 47 |
| Reports - Evaluative | 8 |
| Reports - Descriptive | 7 |
| Information Analyses | 1 |
| Opinion Papers | 1 |
| Tests/Questionnaires | 1 |
Education Level
| Elementary Education | 3 |
| Early Childhood Education | 1 |
| High Schools | 1 |
| Kindergarten | 1 |
| Middle Schools | 1 |
Audience
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
| Beck Depression Inventory | 1 |
| Child Behavior Checklist | 1 |
| Manifest Anxiety Scale | 1 |
| Social Phobia and Anxiety… | 1 |
| Vineland Adaptive Behavior… | 1 |
What Works Clearinghouse Rating
Peer reviewedPatel, Nick C.; Crismon, M. Lynn; Hoagwood, Kimberly; Johnsrud, Michael T.; Rascati, Karen L.; Wilson, James P.; Jensen, Peter S. – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
Objective: To estimate prevalence rates of antipsychotic use in children and adolescents from 1996 to 2001 in three state Medicaid programs (midwestern [MM], southern [SM], and western [WM]) and one private managed care organization (MCO). Method: Prescription claims were used to evaluate antipsychotic prevalence, defined as the number of children…
Descriptors: Psychiatry, Incidence, Adolescents, Outcomes of Treatment
Peer reviewedSallinen, Bethany J.; Nangle, Douglas W.; O'Grady, April C. – Journal of the American Academy of Child and Adolescent Psychiatry, 2004
The aim of this study was to evaluate the effectiveness of the addition of manual-based cognitive-behavioral therapy to a medication regimen of clomipramine and fluoxetine and the withdrawal of medication during cognitive-behavioral therapy. The participant was an 11-year-old girl with symptoms of obsessive thoughts about germs and illness and…
Descriptors: Therapy, Psychiatry, Outcomes of Treatment, Cognitive Restructuring
Peer reviewedKafantaris, Vivian; Coletti, Daniel J.; Dicker, Robert; Padula, Gina; Pleak, Richard R.; Alvir, Jose Ma. J.; Kane, John M. – Journal of the American Academy of Child and Adolescent Psychiatry, 2004
Objective: There are no published placebo-controlled studies of any agent in the treatment of acute mania in children or adolescents. This is the first placebo-controlled study of lithium's efficacy in the treatment of acute mania in adolescents. Method: In this discontinuation study, participants received open treatment with lithium at…
Descriptors: Psychiatry, Adolescents, Statistical Significance, Drug Therapy
Direct linkZonnevylle-Bender, Marjo J. S.; Matthys, Walter; van de Wiel, Nicolle M. H.; Lochman, John E. – Journal of the American Academy of Child and Adolescent Psychiatry, 2007
Objective: Disruptive behavior disorder (DBD) is a well-known risk factor for substance abuse and delinquent behavior in adolescence. Therefore, the long-term preventive effects of treatment of DBD in middle childhood on beginning substance use and delinquency in early adolescence were investigated. Method: Children with DBD (8-13 years old) had…
Descriptors: Foreign Countries, Early Adolescents, Therapy, Behavior Modification
Findling, Robert L.; McNamara, Nora K.; Stansbrey, Robert; Gracious, Barbara L.; Whipkey, Resaca E.; Demeter, Christine A.; Reed, Michael D.; Youngstrom, Eric A.; Calabrese, Joseph R. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: It has been reported that bipolar disorder may become less responsive to previously effective treatment with each symptomatic relapse. The primary goal of this study was to assess the rate of restabilization after the resumption of lithium ([Li[superscript +]) plus divalproex (DVPX) following relapse on either agent as monotherapy.…
Descriptors: Drug Therapy, Patients, Mental Disorders, Depression (Psychology)
Donnelly, Craig L.; Wagner, Karen Dineen; Rynn, Moira; Ambrosini, Paul; Landau, Phyllis; Yang, Ruoyong; Wohlberg, Christopher J. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To explore time to first response and time to first persistent response of sertraline versus placebo and compare these parameters between children (6-11 years old, n = 177) and adolescents (12-17 years old, n = 199) with major depressive disorder. Method: A 10-week placebo-controlled treatment was followed by a 24-week open-label…
Descriptors: Adolescents, Depression (Psychology), Drug Therapy, Comparative Analysis
Peer reviewedKatz, Debra A.; Hays, Lon R. – Journal of the American Academy of Child and Adolescent Psychiatry, 2004
OxyContin, a prescription pain reliever, is a controlled-release form of oxycodone hydrochloride. The medication is supplied in 10-mg, 20-mg, 40-mg, and 80-mg tablets and provides delivery of oxycodone over a 12-hour period. It is indicated for the management of moderate to severe pain. Although all prescription narcotics have the potential for…
Descriptors: Narcotics, Drug Abuse, Adolescents, Outcomes of Treatment
Lyons, John S.; McCulloch, Jill Romansky – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
This article discusses the response of Illinois Department of Children and Family Services (IDCFS) to the perceived problems with long-term residential treatment and psychiatric hospitalization. The IDCFS implemented a process of residential placement review and a system of residential facility gatekeepers to ensure more appropriate placement and…
Descriptors: Placement, Foster Care, Community Services, Emotional Disturbances
West, Amy E.; Henry, David B.; Pavuluri, Mani N. – Journal of the American Academy of Child and Adolescent Psychiatry, 2007
Objective: The chronic and refractory course of pediatric bipolar disorder merits the study of adjunctive psychosocial interventions designed to facilitate long-term improvements. The objective of this study is to conduct a pilot study of a maintenance model of the child- and family-focused cognitive-behavioral therapy program (CFF-CBT), which…
Descriptors: Patients, Maintenance, Pediatrics, Feasibility Studies
Delbello, Melissa P.; Kowatch, Robert A.; Adler, Caleb M.; Stanford, Kevin E.; Welge, Jeffrey A.; Barzman, Drew H.; Nelson, Erik; Strakowski, Stephen M. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To determine the comparative efficacy of quetiapine and divalproex for the treatment of adolescent mania. Method: Fifty adolescents (ages 12-18 years) with bipolar I disorder, manic or mixed episode, were randomized to quetiapine (400-600 mg/day) or divalproex (serum level 80-120 [micro]g/mL) for 28 days for this double-blind study,…
Descriptors: Rating Scales, Adolescents, Pilot Projects, Drug Therapy
Greenhill, Laurence L.; Biederman, Joseph; Boellner, Samuel W.; Rugino, Thomas A.; Sangal, R. Bart; Earl, Craig Q.; Jiang, John G.; Swanson, James M. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To evaluate the efficacy and tolerability of modafinil in children and adolescents, ages 7 to 17, with attention-deficit/hyperactivity disorder (ADHD). Method: In this 9-week, double-blind, flexible-dose study, patients were randomized to once-daily modafinil (170-425 mg) or placebo. Assessments included ADHD Rating Scale-IV…
Descriptors: Patients, Adolescents, Hyperactivity, Attention Deficit Disorders
Spencer, Thomas J.; Faraone, Stephen V.; Biederman, Joseph; Lerner, Marc; Cooper, Kimberly M.; Zimmerman, Brenda – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To investigate whether prolonged therapy with a long-acting stimulant affects growth in children with attention-deficit/hyperactivity disorder (ADHD). Method: One hundred seventy-eight children ages 6 to 13 years received OROS methylphenidate (OROS MPH, CONCERTA) for at least 21 months. Height and weight were measured monthly during the…
Descriptors: Body Height, Body Weight, Drug Therapy, Stimulants
Tonge, Bruce; Brereton, Avril; Kiomall, Melissa; MacKinnon, Andrew; King, Neville; Rinehart, Nicole – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To determine the impact of a parent education and behavior management intervention (PEBM) on the mental health and adjustment of parents with preschool children with autism. Method: A randomized, group-comparison design involving a parent education and counseling intervention to control for nonspecific therapist effects and a control…
Descriptors: Early Intervention, Caregivers, Preschool Children, Autism
McGough, James; McCracken, James; Swanson, James; Riddle, Mark; Kollins, Scott; Greenhill, Laurence; Abikoff, Howard; Davies, Mark; Chuang, Shirley; Wigal, Tim; Wigal, Sharon; Posner, Kelly; Skrobala, Anne; Kastelic, Elizabeth; Ghuman, Jaswinder; Cunningham, Charles; Shigawa, Sharon; Moyzis, Robert; Vitiello, Benedetto – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: The authors explored genetic moderators of symptom reduction and side effects in methylphenidate-treated preschool-age children diagnosed with attention-deficit/hyperactivity disorder (ADHD). Method: DNA was isolated from 81 subjects in a double-blind, placebo-controlled, crossover methylphenidate titration. Parents and teachers…
Descriptors: Hyperactivity, Genetics, Attention Deficit Disorders, Drug Therapy
Kratochvil, Christopher; Emslie, Graham; Silva, Susan; McNulty, Steve; Walkup, John; Curry, John; Reinecke, Mark; Vitiello, Benedetto; Rohde, Paul; Feeny, Nora; Casat, Charles; Pathak, Sanjeev; Weller, Elizabeth; May, Diane; Mayes, Taryn; Robins, Michele; March, John – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To examine the time to response for both pharmacotherapy and psychotherapy in the Treatment for Adolescents with Depression Study (TADS). Method: Adolescents (N = 439, ages 12 to 17 years) with major depressive disorder were randomized to fluoxetine (FLX), cognitive-behavioral therapy (CBT), their combination (COMB), or pill placebo…
Descriptors: Psychotherapy, Probability, Adolescents, Depression (Psychology)
